To present initial clinical comparison between high-power holmium laser with MOSES technology (HPH-M) and thulium fiber laser (TFL) during mini-percutaneous nephrolithotomy (PCNL) for renal calculi with specific emphasis on fragmentation efficiency, fragment size distribution, and stone-free rates (SFRs). Between August 2018 and December 2019, we performed mini-PCNL for renal calculi <3 cm using HPH-M (Lumenis, Israel) or TFL (Urolase SP, IPG Photonics). Data were collected prospectively in our institutional stone registry. Propensity score matching (1:1) was performed using stone size and density as predictors resulting in matched cohort of 51 patients in each group. Mini-PCNL with active suction sheath was standard across all patients. Primary end-point was SFR at immediate postprocedure and 1 month using CT/kidney, ureter, and bladder radiograph. Stone fragments were retrieved and segregated to assess proportion of dust (<1 mm), small (1-3 mm), and large (>3 mm) fragments. Both groups were comparable in terms of stone size ( = 0.74), volume ( = 0.17), and density ( = 0.69). SFR at 48 hours was 78.43% in HPH-M group and 68.63% in TFL group. Patients with residual fragments were completely clear at 1 month. Lasing time (678.6 551.95 seconds;  = 0.17), stone fragmentation rate (4.6 5.2 mm/s;  = 0.23), and total laser energy (21.9 16.3 KJ;  = 0.09) were comparable in both arms. Both groups produced similar dusting (46.8 46.41%;  = 0.93). TFL produced a greater proportion of fragments >3 mm (36% 22.68%,  = 0.002). On subset analysis based on stone density, all outcome parameters were comparable except a shorter total operative time with TFL ( ≤ 0.05). HPH-M and TFL showed similar SFR. Within constraints of the laser fiber size and energy settings, both modalities were equivalent in terms of fragmentation efficiency and proportion of dusting across stone densities.

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2021.0915DOI Listing

Publication Analysis

Top Keywords

high-power holmium
8
moses technology
8
thulium fiber
8
fiber laser
8
renal calculi
8
fragmentation efficiency
8
holmium moses
4
technology thulium
4
laser
4
laser miniperc
4

Similar Publications

The global increase in urolithiasis prevalence has led to a shift towards minimally invasive procedures, such as retrograde intrarenal surgery, supported by advancements in laser technologies for lithotripsy. Pulsed lasers, particularly the holmium YAG and the newer thulium fiber laser, have significantly transformed the management of upper urinary tract stones. However, the use of high-power lasers in these procedures introduces risks of heat-related injury.

View Article and Find Full Text PDF

We aim to evaluate stone-free rate (SFR) and complications after flexible ureteroscopy (F-URS) for kidney stones, using a flexible and navigable suction ureteral access sheath (FANS), comparing thulium fiber laser (TFL) and high-power holmium:yttrium-aluminum-garnet laser (HPHL). Data from adults who underwent F-URS in 15 centers were prospectively analyzed (August 2023-January 2024). Exclusion criteria were ureteral stones, concomitant bilateral procedures, and renal abnormalities.

View Article and Find Full Text PDF

Objective: To compare the safety and efficacy of low-power (LP) and high-power (HP) holmium laser enucleation of the prostate (HoLEP) in patients with symptomatic small-volume benign prostatic hyperplasia (BPH).

Methods: In this prospective, multicenter, single-blind, randomized controlled trial, men with symptomatic BPH (prostate volume <40 mL, peak urinary flow rate [Qmax] <10 mL/s, International Prostate Symptom Score [IPSS] ≥18) underwent either LP (24 W) or HP HoLEP (80 W). The primary outcome was IPSS at 6 months postoperatively.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effects of high-power and low-power Holmium laser enucleation of the prostate (HoLEP) on coagulation in patients on antiplatelet therapy, analyzing data from 210 patients across three groups.
  • Results showed no significant differences in baseline characteristics, but notable variations in surgical times, hospital stay, and hemoglobin reduction were found; prostate volume was identified as a key risk factor for hematuria.
  • The conclusion indicates that low-power HoLEP can reduce surgical and recovery times as well as hemoglobin loss, making it a practical choice for patients on antiplatelet therapy without needing to stop their medication.
View Article and Find Full Text PDF

Purpose: Traditionally, bilateral urolithiasis treatment involved staged interventions due to safety concerns. Recent studies have shown that same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) is effective, with acceptable complication rates. However, there's no clear data on the optimum laser for the procedure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!